Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells1
References (45)
- et al.
Use of gallium to treat Paget's disease of bone: a pilot study
Lancet
(1990) - et al.
Gallium inhibits bone resorption by a direct effect on osteoclasts
Bone Miner
(1990) - et al.
Calcium-activated calcium permeability in parathyroid cells
FEBS Lett
(1986) - et al.
Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations
J Biol Chem
(1987) - et al.
Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell
Biochem Biophys Res Commun
(1992) - et al.
Neomycin interacts with Ca2+ sensing of normal and adenomatous parathyroid cells
Mol Cell Endocrinol
(1992) - et al.
A new generation of Ca2+ indicators with greatly improved fluorescence properties
J Biol Chem
(1985) - et al.
Calcium-agonistic action of Mn2+ in the parathyroid cell
Mol Cell Endocrinol
(1988) - et al.
Tissue distribution of gallium following administration of the gallium-maltol complex in the rat: a model for an aluminum-maltol complex of neurotoxicological interest
Food Chem Toxicol
(1988) - et al.
Paradoxical effects of K+ and D-600 on parathyroid hormone secretion and cytoplasmic Ca2+ in normal bovine and pathological human parathyroid cells
Biochim Biophys Acta
(1985)
Dual effects of a new hypocalcemic agent, WR-2721, on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism
Biochem Pharmacol
(1986)
Malignancy hypercalcemia: evaluation of parathyroid function and response to treatment
Am J Med Sci
(1991)
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcemia of malignancy
Bone Miner
(1991)
Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia
J Clin Invest
(1984)
Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis
Cancer Res
(1986)
Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma
Ann Intern Med
(1987)
Gallium nitrate for advanced Paget's disease of bone: effectiveness and dose-response analysis
Ann Intern Med
(1990)
Gallium increases bone calcium and crystallite perfection of hydroxyapatite
Calcif Tissue Int
(1986)
Gallium nitrate for malignant osteolysis: in vitro and clinical effects on parathyroid hormone
Clin Res
(1987)
Pyrophosphate and diphosphonates in skeletal metabolism
Clin Orthop
(1975)
A pharmacological background for the use of APD in cancer
Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts
J Bone Miner Res
(1990)
Cited by (7)
The response of pre-osteoblasts and osteoclasts to gallium containing mesoporous bioactive glasses
2018, Acta BiomaterialiaCitation Excerpt :One of the most interesting therapeutic ions in the field of bone pathologies is Ga (III). The inhibition of bone resorption driven by Ga (III) has been widely reported [31–35]. Ga reduces the resorption activity, differentiation and formation of osteoclasts without cytotoxic effects in a dose-dependent manner, pointing out an excellent potential for the treatment of osteoporotic bone fractures associated to bone implants [36,37].
Hypercalcemia
2015, Textbook of Palliative Medicine and Supportive CareMilk alkali syndrome
2002, Ulster Medical JournalTreatment of malignant hypercalcaemia
2002, Expert Opinion on Pharmacotherapy
- 1
Supported by the Swedish Medical Research Council; Förenade Liv Mutual Group Life Insurance Co., Stockholm; and the Swedish Society of Medicine.
Copyright © 1995 Published by Mosby, Inc.